The Medical Cannabis and Wellness UCITS ETF
A budding opportunity for European investors
The Medical Cannabis and
Wellness UCITS ETF, is a UCITS compliant Exchange Traded Fund domiciled in Ireland.
The fund tracks a rules-based Medical Cannabis and
Wellness Equity Index from Solactive, consisting of publicly listed companies conducting legal
business activities across nine thematic sub-sectors in the medical cannabis, hemp and CBD industries.
The cannabis ETF seeks to provide targeted exposure to the rapidly expanding legal medical cannabis industry that is set for further growth as more countries legalise cannabis for medical use.
Please remember that the value of your investment may go down as well as up and past performance is no indication
of future performance.
View Related Articles
In a single trade, CBDX provides access to a basket of companies from Developed and Emerging markets with high exposure to the medical cannabis, hemp and cannabinoids (CBD) industry.
The only UCITS ETF to provide targeted exposure to a new and growing industry of companies engaged in the production and associated services and products in the medical cannabis industry
CBDX avoids concentration in larger stocks by capping constituent weights at 15% during the quarterly rebalance
+44(0) 203 794 1800
HANetf Ltd, City Tower, 40 Basinghall St,
London, EC2V 5DE
The price of any Shares or the value of an investment in ETPs may go up or down and an investor may not get back the amount invested. Past performance is not a reliable indicator of future performance. This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any financial instrument or product or to adopt any investment strategy. Any decision to invest should be based on the information contained in the appropriate prospectus and after seeking independent investment, tax and legal advice.
These products may not be available in your market or suitable for you. The content of this document does not constitute investment advice nor an offer for sale nor a solicitation of an offer to buy any product or make any investment.
Select Your Country
Please choose one of the following options: